Thomas W Macallister

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Remedy Pharmaceuticals, Inc., Biogen Chesapeake LLC. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas W Macallister. Retrieved from https://idiyas.com/inventor/thomas-w-macallister-pxrz15wl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

5 out of 13

Remedy Pharmaceuticals, Inc.

patents

1 out of 13

Biogen Chesapeake LLC

patents

Years Active: 2022-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734182 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2026-09-15),

2. 12611416 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2026-04-28),

3. 12337006 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-06-24),

4. 12251389 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-03-18),

5. 12251388 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-03-18),

6. 11304963 - Methods of medical treatment with SUR1-TRPM4 channel inhibitors (2022-04-19),

Profile summary based on public USPTO records.